• Cegedim: Strong rebound in first half 2021 revenue

    ソース: Nasdaq GlobeNewswire / 27 7 2021 11:45:00   America/New_York

     
     

    PRESS RELEASE

    Quarterly financial information as of June 30, 2021
    IFRS - Regulated information - Not audited

    Cegedim: Strong rebound in first half 2021 revenue

    • Like-for-like(1) revenue growth reached 6.2% in the first half
    • Like-for-like(1) revenue growth reached 11.7% in the second quarter
    • Revenue growth target revised higher.

    Boulogne-Billancourt, France, July 27, 2021, after the market close

    Cegedim generated consolidated H1 2021 revenues of €251.2 million, an increase of 6.3% as reported and 6.2% like for like (1) compared with the same period in 2020, and up 3.4% compared with 2019.

    Second quarter revenues rose 12.2% as reported and 11.7% like for like(1) compared with the same period in 2020 and 2.6% compared with 2019. This growth reflects the fact that Q2 2020 was hit particularly hard by the pandemic, especially pharmacy media and project-based activities in the health insurance sector. Laurent Labrune, Deputy Managing Director of Cegedim, said:

    “We had a particularly active start to the year. The Group’s innovation efforts paid off in the form of several sizeable contracts in project-based business, notably in the insurance sector. We also launched Cegedim Santé France, a new unit with its own brand aimed at making us more competitive by bundling products and services for the healthcare professional market while also responding to new public health challenges.

    Conditions are still volatile and uncertain, and we are still feeling the impacts of the pandemic, but revenues rose 11.7% like for like in the second quarter of 2021 compared with 2020. This growth reflects our unique positioning within the healthcare space, offering data management, digital technologies, software, flow management, and related services.

    Lastly, the acquisition of two best-in-class companies, Médimust and Kobus Tech, has among other things made Cegedim the top medical software publisher in France(2) and allowed it to meet the needs of more than 100,000 French healthcare professionals”.

    Revenue

      H1 Change H1 2021 / 2020Change H1 2021/2019
    in € millions 20212020ReportedLFL(3)LFL(4)
    Software & Services 140.2133.7+4.9%+4.6%+1.9%
    Flow 41.738.4+8.7%+8.7%+2.6%
    Data & Marketing 44.838.4+16.4%+16.5%+8.8%
    BPO 22.923.9(4.3)%(4.3)%+5.9%
    Corporate and others 1.51.7(12.6)%(12.6)%(12.3)%
    Cegedim 251.2236.2+6.3%+6.2%+3.4%

    (1)   At constant scope and exchange rates.
    (2)   Source: GIE SESAM-Vitale.
    (3)   At constant scope and exchange rates. Acquisitions and divestments had virtually no impact.
    (4)   At constant scope and exchange rates. Exchange rates had virtually no impact. The €3.0 million hit from scope effects, or 1.2pp, was chiefly due to the sale of nearly all of the business activities of Pulse Systems Inc. in the US in August 2019, which was partly offset by the acquisitions of Cosytec in France in July 2019 and NetEDI in the UK in August 2019. The acquisitions of Médimust and Kobus Tech in May 2021 had a marginal impact as of June 30, 2021.

    Analysis of business trends by division

    • Software & Services

    The division’s first half 2021 revenues rose to €140.2 million, up 4.6% like for like(1) compared with 2020 and 1.9% compared with 2019.

    The growth came chiefly from a resurgence of project-based business, particularly in health insurance, following a pause of several months. The Group’s allied health professional computerization business in France and its appointment scheduling, remote health, and HR management solutions were particularly dynamic in the second quarter.

    • Flow

    The division’s first half 2021 revenues rose to €41.7 million, up 8.7% like for like(1) compared with 2020 and 2.6% compared with 2019.

    Process digitalization had a strong quarter across all sectors. After people in France reduced their use of the healthcare system early in the year because of public health restrictions, healthcare flow business increased in the second quarter.

    • Data & Marketing

    The division’s first half 2021 revenues rose to €44.8 million, up 16.5% like for like(1) compared with 2020 and 8.8% compared with 2019.

    Data activities experienced strong growth against the backdrop of the pandemic. Advertising in French pharmacies was again close to its pre-pandemic level.

    • BPO

    The division’s first half 2021 revenues fell to €22.9 million, down 4.3% like for like(1) compared with 2020 but up 5.9% compared with 2019.

    A significant portion of this division’s business is providing services for insurance companies and mutual insurance providers, so it took a hit from public health restrictions that caused people in France reduce their use of the healthcare system.

    • Corporate and others

    The division’s first half 2021 revenues fell to €1.5 million, down 12.6% like for like(1) compared with 2020 and 12.3% compared with 2019.

    Highlights

    To the best of the company’s knowledge, apart from the items listed below, there were no events or changes during the first half of 2021 that would materially alter the Group’s financial situation.

    • Acquisition of Kobus in France

    On April 30, 2021, Cegedim acquired French start-up Kobus Tech, which specializes in patient management for physical therapists (patient care summaries, exercise prescription, mail generation, etc.). Its solution has more than 4,000 users. It is perfectly compatible with Cegedim Santé’s solutions and their combined offering is one of the market’s most comprehensive. It began contributing to the Group’s consolidation scope in May 2021.

    • Acquisition of Médimust in France

    On May 4, 2021, Cegedim acquired Médimust, a software publisher serving healthcare professions for 25 years that currently supplies 2,000 independent physicians. The acquisition cements Cegedim Santé place as France’s number 1 medical software company(2). Pooling the companies’ know-how and expertise is strengthening Cegedim Santé’s range of solutions and improving its ability to adapt to market developments and healthcare professionals’ changing needs.

    Médimust generated revenues of €1.3 million in 2020 and earned a profit. It began contributing to the Group’s consolidation scope in May 2021.

    (1)   At constant scope and exchange rates.
    (2)   Source: GIE SESAM-Vitale.

    Significant transactions and events post June 30, 2021

    To the best of the company’s knowledge, there were no post-closing events or changes that would materially alter the Group’s financial situation.

    Outlook

    Revenues rebounded immediately after the first lockdown, so after a 2.5% like-for-like (1) decrease in first half 2020, we saw like-for-like(1) growth of 2.1% in the second half of 2020. Considering this basis of comparison and H1 2021 growth of 6.2%, the Group is raising its target for like-for-like(1) revenue growth in 2021 from 2% previously to 3-5%.

    This target may need to be revised if the Covid-19 crisis causes a severe tightening of public health restrictions in Europe after this press release is issued.

    The Group will announce any changes to its outlook for recurring operating income(1) growth, currently 4%, when it releases its first half results on September 16, 2021.

    The Group does not expect to make any significant acquisitions in 2021. And lastly, the group does not provide earnings estimates or forecasts.

    WEBCAST ON JULY 27, 2021 AT 6:15 PM (PARIS TIME)
    The webcast is available at: www.cegedim.com/webcast
     
    The H1 2021 revenues presentation is available at:

    • On the website: https://www.cegedim.com/finance/documentation/Pages/presentations.aspx
    • And on the Cegedim IR smartphone app, available at
     

    Financial calendar

    2021September 16 after the close

    September 17

    October 28 after the close    		H1 2021 results

    SFAF meeting

    Q3 2021 revenues


    Disclaimer
    This press release is available in French and in English. In the event of any difference between the two versions, the original French version takes precedence. It was sent to Cegedim’s authorized distributor on July 27, 2021, no earlier than 5:45 pm Paris time.
    The figures cited in this press release include guidance on Cegedim's future financial performance targets. This forward-looking information is based on the opinions and assumptions of the Group’s senior management at the time this press release is issued and naturally entails risks and uncertainty. For more information on the risks facing Cegedim, please refer to Chapter 7, “Risk management”, section 7.2, “Risk factors and insurance”, and Chapter 3, “Overview of the financial year”, section 3.6, “Outlook”, of the 2020 Universal Registration Document filled with the AMF on April 16, 2021 under number D.21-0320.

     
     

    About Cegedim:

    Founded in 1969, Cegedim is an innovative technology and services group in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs more than 5,300 people in more than 10 countries and generated revenue of close to €500 million in 2020.
    Cegedim SA is listed in Paris (EURONEXT: CGM).
    To learn more, please visit: www.cegedim.fr
    And follow Cegedim on Twitter: @CegedimGroup, LinkedIn and Facebook.

    Aude BALLEYDIER
    Cegedim
    Media Relations
    and Communications Manager
    Tél. : +33 (0)1 49 09 68 81
    aude.balleydier@cegedim.fr
    Jan Eryk UMIASTOWSKI
    Cegedim
    Chief Investment and
    Investor Relations Officer
    Tél. : +33 (0)1 49 09 33 36
    janeryk.umiastowski@cegedim.com
    Céline PARDO
    suPR
    Media Relations
    Tél. :        +33 (0)6 52 08 13 66
    cegedim@becoming-group.com    		 

     

    Annexes

    Breakdown of revenue by quarter and division

    • Year 2021
    in € thousands Q1Q2Q3Q4Total
    Software & services 68.871.4  140.2 
    Flow 21.020.7  41.7 
    Data & Marketing 19.924.8  44.8 
    BPO 11.711.2  22.9 
    Corporate and others 1.00.5  1.5 
    Consolidated Group revenue 122.5128.7  251.2 
    • Year 2020
    in € thousands Q1Q2Q3Q4Total
    Software & services 69.164.468.075.5277.2 
    Flow 20.418.019.022.079.4 
    Data & Marketing 18.919.619.030.387.8 
    BPO 12.311.612.013.048.9 
    Corporate and others 0.90.91.01.03.6 
    Consolidated Group revenue 121.5114.7118.9141.8496.9 

    Breakdown of revenue by geographic zone and division as of June 30, 2021

    as a % of consolidated revenues FranceEMEA ex. FranceAmericas
    Software & services 81.7%18.2%0.1%
    Flow 93.8%6.2%0.0%
    Data & Marketing 97.2%2.8%0.0%
    BPO 100.0%0.0%0.0%
    Corporate and others 99.6%0.4%0.0%
    Cegedim 88.2%11.7%0.1%

    Breakdown of revenue by currency and division as of June 30, 2021

    as a % of consolidated revenues EuroGBPOthers
    Software & services 84.5%13.5%2.0%
    Flow 96.6%3.4%0.0%
    Data & Marketing 97.2%0.0%2.8%
    BPO 100.0%0.0%0.0%
    Corporate and others 100.0%0.0%0.0%
    Cegedim 90.3%8.1%1.6%

    H1 2021 Revenue by sector

      H1
    in € millions 20212020LFL change(1)Reported chg.
    Health insurance, HR and e-services 176.6160.3+10.2%+10.1%
    Healthcare professionals 73.074.1(1.5)%(1.8)%
    Corporate and others 1.51.7(12.6)%(12.6)%
    Cegedim 251.2236.2+6.3%+6.2%

    Sector / division comparison

      H1 2021
    in € millions Health insurance, HR and e-servicesHealthcare professionalsCorporate and othersTotal
    Software & services 67.273.0-140.2
    Flow 41.7--41.7
    Data & Marketing 44.8--44.8
    BPO 22.9--22.9
    Corporate and others --1.51.5
    Cegedim 176.673.01.5251.2

    Q2 2021 Revenue by division

      Q2Change Q2 2021 / 2020Change Q2 2021/2019
    in € millions 20212020ReportedLFL(1)LFL(2)
    Software & Services 71.464.6+10.6%+9.7%+0.7%
    Flow 20.718.0+14.8%+14.7%+0.9%
    Data & Marketing 24.819.6+26.9%+26.9%+11.7%
    BPO 11.211.6(3.2)%(3.2)%+3.7%
    Corporate and others 0.50.9(45.5)%(45.5)%(43.2)%
    Cegedim 128.7114.7+12.2%+11.7%+2.6%

    (1)   At constant scope and exchange rates. Acquisitions and divestments had a positive impact of 0.2pp, exchange rates had a positive impact of 0.3pp due to the pound sterling.
    (2)   At constant scope and exchange rates. Exchange rates had virtually no impact. The €1.3 million hit from scope effects, or 1.1pp, was chiefly due to the sale of nearly all of the business activities of Pulse Systems Inc. in the US in August 2019, which was partly offset by the acquisitions of Cosytec in France in July 2019 and NetEDI in the UK in August 2019. The acquisitions of Médimust and Kobus Tech in May 2021 had a marginal impact as of June 30, 2021.

    Attachment


シェアする